Dimension Therapeutics (DMTX) Priced

Developing novel, liver-directed gene therapies for rare genetic disorders.

Health Care - Biotechnology

IPO Performance
Latest Trade $1.90 0.00 (0.0%)
First Day Return -16.9%
Return from IPO -85.4%
 
Dimension Therapeutics IPO News more
  • .
IPO Data
IPO File Date 09/14/2015
Offer Price $13.00
Price Range $14.00 - $16.00
Offer Shares (mm) 5.5
Deal Size ($mm) 72
 
IPO Data
IPO Date 10/21/2015
Offer Price $13.00
Price Range $14.00 - $16.00
Offer Shares (mm) 5.5
Deal Size ($mm) $72
 
Underwriters
more
Business Overview
Developing novel, liver-directed gene therapies for rare genetic disorders.
Developing novel, liver-directed gene therapies for rare genetic disorders.
more
Company Data
Headquarters Cambridge, MA
Founded 2013
Employees 49
Website www.dimensiontx.com
 

Performance vs. IPO Index (IPOUSA)